Yaoyao Wu

In silico design of small molecules targeting cathepsin-k for the treatment of osteoarthritis

Shenghong Zhang, Yaoyao Wu, 2018, Tropical Journal of Pharmaceutical Research.

Discovery of potent, orally bioavailable ERK1/2 inhibitors with isoindolin-1-one structure by structure-based drug design.

Qihua Zhu, Ying Bai, Yungen Xu, 2019, European journal of medicinal chemistry.

Discovery of Novel Dual Bruton’s Tyrosine Kinase (BTK) and Janus Kinase 3 (JAK3) Inhibitors as A Promising Strategy for Rheumatoid Arthritis

Haifeng Zhang, Qihua Zhu, Ming-Fu Cheng, 2023, Bioorganic & Medicinal Chemistry.